CROCS INC (CROX)

US2270461096 - Common Stock

111.86  +6.18 (+5.85%)

After market: 111.8 -0.06 (-0.05%)

Fundamental Rating

7

Taking everything into account, CROX scores 7 out of 10 in our fundamental rating. CROX was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the health and profitability get an excellent rating, making CROX a very profitable company, without any liquidiy or solvency issues. CROX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, CROX could be worth investigating further for value and quality investing!.



9

1. Profitability

1.1 Basic Checks

In the past year CROX was profitable.
In the past year CROX had a positive cash flow from operations.
CROX had positive earnings in each of the past 5 years.
In the past 5 years CROX always reported a positive cash flow from operatings.

1.2 Ratios

CROX has a better Return On Assets (17.71%) than 94.00% of its industry peers.
Looking at the Return On Equity, with a value of 48.39%, CROX belongs to the top of the industry, outperforming 98.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 21.93%, CROX belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CROX is significantly above the industry average of 11.70%.
The last Return On Invested Capital (21.93%) for CROX is well below the 3 year average (30.08%), which needs to be investigated, but indicates that CROX had better years and this may not be a problem.
Industry RankSector Rank
ROA 17.71%
ROE 48.39%
ROIC 21.93%
ROA(3y)25.34%
ROA(5y)24.04%
ROE(3y)1755.79%
ROE(5y)1093.13%
ROIC(3y)30.08%
ROIC(5y)27.47%

1.3 Margins

The Profit Margin of CROX (20.50%) is better than 100.00% of its industry peers.
CROX's Profit Margin has declined in the last couple of years.
CROX has a better Operating Margin (26.15%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of CROX has grown nicely.
Looking at the Gross Margin, with a value of 58.15%, CROX is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 26.15%
PM (TTM) 20.5%
GM 58.15%
OM growth 3Y13.61%
OM growth 5Y32.68%
PM growth 3Y-3.95%
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y1.62%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CROX is creating value.
Compared to 1 year ago, CROX has less shares outstanding
The number of shares outstanding for CROX has been reduced compared to 5 years ago.
CROX has a better debt/assets ratio than last year.

2.2 Solvency

CROX has an Altman-Z score of 3.87. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.87, CROX is doing good in the industry, outperforming 76.00% of the companies in the same industry.
The Debt to FCF ratio of CROX is 1.51, which is an excellent value as it means it would take CROX, only 1.51 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 1.51, CROX is doing good in the industry, outperforming 78.00% of the companies in the same industry.
A Debt/Equity ratio of 0.82 indicates that CROX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.82, CROX is not doing good in the industry: 72.00% of the companies in the same industry are doing better.
Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 1.51
Altman-Z 3.87
ROIC/WACC2.51
WACC8.75%

2.3 Liquidity

A Current Ratio of 1.43 indicates that CROX should not have too much problems paying its short term obligations.
CROX's Current ratio of 1.43 is on the low side compared to the rest of the industry. CROX is outperformed by 78.00% of its industry peers.
CROX has a Quick Ratio of 1.43. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.90, CROX is doing worse than 68.00% of the companies in the same industry.
CROX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.9

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.17% over the past year.
The Earnings Per Share has been growing by 55.01% on average over the past years. This is a very strong growth
Looking at the last year, CROX shows a small growth in Revenue. The Revenue has grown by 3.16% in the last year.
CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.49% yearly.
EPS 1Y (TTM)9.17%
EPS 3Y55.01%
EPS 5YN/A
EPS Q2Q%10.77%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y41.93%
Revenue growth 5Y29.49%
Sales Q2Q%1.58%

3.2 Future

CROX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.01% yearly.
Based on estimates for the next years, CROX will show a small growth in Revenue. The Revenue will grow by 3.71% on average per year.
EPS Next Y9.49%
EPS Next 2Y5.15%
EPS Next 3Y5.15%
EPS Next 5Y1.01%
Revenue Next Year2.92%
Revenue Next 2Y2.99%
Revenue Next 3Y3.41%
Revenue Next 5Y3.71%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.47, which indicates a very decent valuation of CROX.
Compared to the rest of the industry, the Price/Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 96.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.73. CROX is valued rather cheaply when compared to this.
CROX is valuated reasonably with a Price/Forward Earnings ratio of 8.41.
96.00% of the companies in the same industry are more expensive than CROX, based on the Price/Forward Earnings ratio.
CROX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.83.
Industry RankSector Rank
PE 8.47
Fwd PE 8.41

4.2 Price Multiples

CROX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CROX is cheaper than 86.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 90.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.93
EV/EBITDA 6.54

4.3 Compensation for Growth

CROX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CROX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2Y5.15%
EPS Next 3Y5.15%

0

5. Dividend

5.1 Amount

CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (12/20/2024, 8:04:00 PM)

After market: 111.8 -0.06 (-0.05%)

111.86

+6.18 (+5.85%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)02-13 2025-02-13/amc
Inst Owners92.63%
Inst Owner Change-2.83%
Ins Owners6.04%
Ins Owner Change-0.81%
Market Cap6.52B
Analysts81.74
Price Target140.49 (25.59%)
Short Float %8.03%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.09%
Min EPS beat(2)10.34%
Max EPS beat(2)13.84%
EPS beat(4)4
Avg EPS beat(4)15.92%
Min EPS beat(4)6.63%
Max EPS beat(4)32.88%
EPS beat(8)8
Avg EPS beat(8)14.84%
EPS beat(12)12
Avg EPS beat(12)15.33%
EPS beat(16)16
Avg EPS beat(16)21.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)-0.82%
Revenue beat(4)1
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)4.37%
Revenue beat(8)3
Avg Revenue beat(8)0.12%
Revenue beat(12)6
Avg Revenue beat(12)0.54%
Revenue beat(16)10
Avg Revenue beat(16)1.74%
PT rev (1m)-15.35%
PT rev (3m)-15.18%
EPS NQ rev (1m)-0.12%
EPS NQ rev (3m)-23.02%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)0.63%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-6.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.07%
Valuation
Industry RankSector Rank
PE 8.47
Fwd PE 8.41
P/S 1.6
P/FCF 6.93
P/OCF 6.39
P/B 3.78
P/tB N/A
EV/EBITDA 6.54
EPS(TTM)13.21
EY11.81%
EPS(NY)13.3
Fwd EY11.89%
FCF(TTM)16.13
FCFY14.42%
OCF(TTM)17.51
OCFY15.65%
SpS69.88
BVpS29.6
TBVpS-13.21
PEG (NY)0.89
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.71%
ROE 48.39%
ROCE 26.49%
ROIC 21.93%
ROICexc 23%
ROICexgc 65.85%
OM 26.15%
PM (TTM) 20.5%
GM 58.15%
FCFM 23.09%
ROA(3y)25.34%
ROA(5y)24.04%
ROE(3y)1755.79%
ROE(5y)1093.13%
ROIC(3y)30.08%
ROIC(5y)27.47%
ROICexc(3y)34.42%
ROICexc(5y)32.34%
ROICexgc(3y)64.19%
ROICexgc(5y)51.43%
ROCE(3y)36.32%
ROCE(5y)33.17%
ROICexcg growth 3Y28.37%
ROICexcg growth 5Y5.67%
ROICexc growth 3Y-8.6%
ROICexc growth 5Y-8.68%
OM growth 3Y13.61%
OM growth 5Y32.68%
PM growth 3Y-3.95%
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y1.62%
F-Score8
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 1.51
Debt/EBITDA 1.26
Cap/Depr 121.9%
Cap/Sales 1.97%
Interest Coverage 9.46
Cash Conversion 90.25%
Profit Quality 112.63%
Current Ratio 1.43
Quick Ratio 0.9
Altman-Z 3.87
F-Score8
WACC8.75%
ROIC/WACC2.51
Cap/Depr(3y)1958.37%
Cap/Depr(5y)1235.7%
Cap/Sales(3y)21.95%
Cap/Sales(5y)14.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.17%
EPS 3Y55.01%
EPS 5YN/A
EPS Q2Q%10.77%
EPS Next Y9.49%
EPS Next 2Y5.15%
EPS Next 3Y5.15%
EPS Next 5Y1.01%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y41.93%
Revenue growth 5Y29.49%
Sales Q2Q%1.58%
Revenue Next Year2.92%
Revenue Next 2Y2.99%
Revenue Next 3Y3.41%
Revenue Next 5Y3.71%
EBIT growth 1Y1.18%
EBIT growth 3Y61.25%
EBIT growth 5Y71.81%
EBIT Next Year2.83%
EBIT Next 3Y1.08%
EBIT Next 5Y0.91%
FCF growth 1Y155.38%
FCF growth 3Y53.59%
FCF growth 5Y51.47%
OCF growth 1Y122.43%
OCF growth 3Y51.63%
OCF growth 5Y52.13%